SCHEMBL4197315

SCHEMBL4197315

ClC1=Nc2cccc3cccc(c23)N1

nearest known ligand 0.62

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
GAA P10253 11/20 0.62
MAPT P10636 9/20 0.62
MCL1 Q07820 3/20 0.62
NPC1 O15118 3/20 0.60
KMT2A Q03164 12/20 0.57
MEN1 O00255 10/20 0.57
LMNA P02545 5/20 0.57
KDM4E B2RXH2 3/20 0.57
USP2 O75604 2/20 0.57
APAF1 O14727 1/20 0.57
PLCG1 P19174 1/20 0.57
CCR6 P51684 1/20 0.57
TDP1 Q9NUW8 1/20 0.57
L3MBTL1 Q9Y468 1/20 0.57
SMN1; SMN2 Q16637 3/20 0.56
CYP1A2 P05177 2/20 0.56
CYP2D6 P10635 2/20 0.56
CYP3A4 P08684 1/20 0.56
CYP2C9 P11712 1/20 0.56
CYP2C19 P33261 1/20 0.56

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL15018298 0.80 KMT2A (0.77) GAAMAPTMCL1NPC1KMT2A
SCHEMBL6527367 0.78 GAA (0.65) GAAMAPTMCL1NPC1KMT2A
SCHEMBL8485540 0.77 GAA (1.00) GAAMAPTMCL1NPC1KMT2A
SCHEMBL1268566 0.77 GAA (0.62) GAAMAPTMCL1NPC1KMT2A
SCHEMBL1773293 0.77 GAA (0.62) GAAMAPTMCL1NPC1KMT2A
SCHEMBL315396 0.77 GAA (0.62) GAAMAPTMCL1NPC1KMT2A
SCHEMBL15040701 0.77 GAA (0.62) GAAMAPTMCL1NPC1KMT2A
SCHEMBL11279534 0.76 KMT2A (0.74) GAAMAPTMCL1NPC1KMT2A
Hydrochloric Acid SCHEMBL8649799 0.76 GAA (0.61) GAAMAPTMCL1NPC1KMT2A
Bromide SCHEMBL9555445 0.76 GAA (0.61) GAAMAPTMCL1NPC1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 12 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-11753426-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and organic light-emitting apparatus including the organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-12 US disclosed
US-11753426-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and organic light-emitting apparatus including the organic light-emitting device SAMSUNG DISPLAY CO., LTD. (KR) 2023-09-12 US disclosed
US-20190263849-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ORGANIC LIGHT-EMITTING APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE SAMSUNG DISPLAY CO., LTD. (KR) 2019-08-29 US disclosed
US-8449989-B2 Organic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2013-05-28 US disclosed
EP-1680479-B1 NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEMICAL LTD (KR) 2012-11-28 EP disclosed
US-20090121622-A1 NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD (KR) 2009-05-14 US disclosed
US-7455917-B2 Organic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2008-11-25 US disclosed
US-7455917-B2 Organic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2008-11-25 US disclosed
US-7455917-B2 Organic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2008-11-25 US disclosed
EP-1680479-A1 NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG Chem, Ltd. (KR) 2006-07-19 EP disclosed
US-20050123800-A1 Organic compound and organic light emitting device using the same LG CHEM, LTD. (KR) 2005-06-09 US disclosed
WO-2005037954-A1 NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LG CHEM, LTD. (KR) 2005-04-28 WO disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (4 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20190263849-A1 ORGANOMETALLIC COMPOUND, ORGANIC LIGHT-EMITTING DEVICE INCLUDING THE ORGANOMETALLIC COMPOUND, AND ORGANIC LIGHT-EMITTING APPARATUS INCLUDING THE ORGANIC LIGHT-EMITTING DEVICE L1CAM, L3MBTL1, MSL1 GAA 3022/4885MAPT 867/4885MCL1 917/4885
US-11753426-B2 Organometallic compound, organic light-emitting device including the organometallic compound, and organic light-emitting apparatus including the organic light-emitting device L1CAM, L3MBTL1, MSL1 GAA 3022/4885MAPT 867/4885MCL1 917/4885
US-20050123800-A1 Organic compound and organic light emitting device using the same LEF1, CYBA, AOX1 GAA 1651/4885MAPT 1317/4885MCL1 3838/4885
US-20090121622-A1 NEW ORGANIC COMPOUND AND ORGANIC LIGHT EMITTING DEVICE USING THE SAME LEF1, CYBA, AOX1 GAA 1367/4885MAPT 1255/4885MCL1 4029/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.